Medii Plus (CEO Jeong Ji-hee) announced that it was selected as a company to advance to the Boston finals of the US Mass Challenge, a global startup competition.
MassChallenge is the world’s largest early stage venture competition held every year in Boston, Massachusetts. About 100 startups out of 5,000 applicants from around the world will be selected as participating companies in the finals, and the teams that advance to the finals will be provided with a three-month online and offline acceleration program and will be eligible to be selected as the final winning team.
MediI Plus operates ‘MediC’, a customized clinical trial information subscription service based on AI and big data. We collect, process, and analyze clinical trial data to provide optimal information necessary for the clinical trial preparation process.
The goal is to improve health and medical care by streamlining the clinical trial process, and was selected as a team that advanced to the finals of this Mass Challenge in recognition of the technology, impact of the item, and growth potential.
Jeong Ji-hee, CEO of Mediai Plus, said, “We are planning to enter the United States in 2023 based on our advancement to the 2022 Mass Challenge finals,” and expressed her ambition, “We will continue to develop good services as a partner not only for domestic but also global pharmaceutical companies and bio venture companies.”
Meanwhile, Media I Plus is a beneficiary of the ‘Global Star Venture’ program supported by the Ministry of SMEs and Startups and hosted by the Gyeonggi Innovation Center.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2022’ news